Kriska BioTech ApS: Financial statements 2022
CVR: 37591971
Source: annual report 2022, Danish Business Authority
01/10/2021 – 30/09/2022
Kriska BioTech ApS (CVR 37591971) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -87,515 and a net result of DKK -120,331 compared with DKK 128 the year before. Equity in the 2022 report amounted to DKK -269,749.
- Gross Profit
- DKK -87,515
- Profit/Loss
- DKK -120,331
- Equity
- DKK -269,749
- Total Assets
- DKK 201,975
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -88 t. | -120 t. | -270 t. | - |
| 2021 | - | 39 t. | 128 | -149 t. | 1 |
| 2020 | - | -27 t. | -55 t. | -150 t. | 1 |
| 2019 | - | -33 t. | -175 t. | -94 t. | 1 |
| 2018 | - | 103 t. | 44 t. | 81 t. | 1 |
Official annual report
Keep an eye on Kriska BioTech ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Kriska BioTech ApS has published its annual report for 2021. Gross profit came to DKK 38,894, and the net result was DKK 128.
About Kriska BioTech ApS
Kriska BioTech ApS is a Danish company of the type Anpartsselskab based in Gedsted, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Hans Karsten Kristoffersen. The company is owned by Hans Karsten Holding ApS. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK -25,405 and a net result of DKK -49,612 compared with DKK -44,384 the year before. Equity in the 2025 report amounted to DKK -425,023.